BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 16533768)

  • 21. Polymorphisms in the KDR and POSTN genes: association with breast cancer susceptibility and prognosis.
    Försti A; Jin Q; Altieri A; Johansson R; Wagner K; Enquist K; Grzybowska E; Pamula J; Pekala W; Hallmans G; Lenner P; Hemminki K
    Breast Cancer Res Treat; 2007 Jan; 101(1):83-93. PubMed ID: 16807673
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ABCB1 and GST polymorphisms associated with TP53 status in breast cancer.
    Nordgard SH; Ritchie MD; Jensrud SD; Motsinger AA; Alnaes GI; Lemmon G; Berg M; Geisler S; Moore JH; Lønning PE; Børresen-Dale AL; Kristensen VN
    Pharmacogenet Genomics; 2007 Feb; 17(2):127-36. PubMed ID: 17301692
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nested case-control study of energy regulation candidate gene single nucleotide polymorphisms and breast cancer.
    Wang Y; McCullough ML; Stevens VL; Rodriguez C; Jacobs EJ; Teras LR; Pavluck AL; Thun MJ; Calle EE
    Anticancer Res; 2007; 27(1B):589-93. PubMed ID: 17348446
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intercellular adhesion molecule-1 genetic markers (+241G/A and +469A/G) in Iranian women with breast cancer.
    Arandi N; Talei A; Erfani N; Ghaderi A
    Cancer Genet Cytogenet; 2008 May; 183(1):9-13. PubMed ID: 18474291
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Progesterone receptor polymorphisms and risk of breast cancer: results from two Australian breast cancer studies.
    Johnatty SE; Spurdle AB; Beesley J; Chen X; Hopper JL; Duffy DL; Chenevix-Trench G;
    Breast Cancer Res Treat; 2008 May; 109(1):91-9. PubMed ID: 17592773
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect modification by catalase genotype suggests a role for oxidative stress in the association of hormone replacement therapy with postmenopausal breast cancer risk.
    Quick SK; Shields PG; Nie J; Platek ME; McCann SE; Hutson AD; Trevisan M; Vito D; Modali R; Lehman TA; Seddon M; Edge SB; Marian C; Muti P; Freudenheim JL
    Cancer Epidemiol Biomarkers Prev; 2008 May; 17(5):1082-7. PubMed ID: 18483329
    [TBL] [Abstract][Full Text] [Related]  

  • 27. No association of polymorphisms in the cell polarity gene SCRIB with breast cancer risk.
    Dünnebier T; Schlaefer K; Gilbert M; Baisch C; Justenhoven C; Brauch H; Harth V; Spickenheuer A; Rabstein S; Pesch B; Brüning T; Ko YD; Hamann U
    Breast Cancer Res Treat; 2011 May; 127(1):259-64. PubMed ID: 20936341
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association among polymorphisms in the steroid 5alpha-reductase type II (SRD5A2) gene, prostate cancer risk, and pathologic characteristics of prostate tumors in an Ecuadorian population.
    Paz-y-Miño C; Witte T; Robles P; Llumipanta W; Díaz M; Arévalo M
    Cancer Genet Cytogenet; 2009 Mar; 189(2):71-6. PubMed ID: 19215786
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A systematic approach to analysing gene-gene interactions: polymorphisms at the microsomal epoxide hydrolase EPHX and glutathione S-transferase GSTM1, GSTT1, and GSTP1 loci and breast cancer risk.
    Spurdle AB; Chang JH; Byrnes GB; Chen X; Dite GS; McCredie MR; Giles GG; Southey MC; Chenevix-Trench G; Hopper JL
    Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):769-74. PubMed ID: 17416769
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Breast cancer risk is not associated with polymorphic forms of xeroderma pigmentosum genes in a cohort of women from Washington County, Maryland.
    Jorgensen TJ; Visvanathan K; Ruczinski I; Thuita L; Hoffman S; Helzlsouer KJ
    Breast Cancer Res Treat; 2007 Jan; 101(1):65-71. PubMed ID: 16823510
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A region of deletion on chromosome 22q13 is common to human breast and colorectal cancers.
    Castells A; Gusella JF; Ramesh V; Rustgi AK
    Cancer Res; 2000 Jun; 60(11):2836-9. PubMed ID: 10850424
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A genetic variant located in miR-423 is associated with reduced breast cancer risk.
    Smith RA; Jedlinski DJ; Gabrovska PN; Weinstein SR; Haupt L; Griffiths LR
    Cancer Genomics Proteomics; 2012; 9(3):115-8. PubMed ID: 22593246
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polymorphisms in the ICAM gene locus are not associated with breast cancer Risk.
    Cox DG; Hankinson SE; Hunter DJ
    Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):178-9. PubMed ID: 16434609
    [No Abstract]   [Full Text] [Related]  

  • 34. SNPs/pools: a methodology for the identification of relevant SNPs in breast cancer epidemiology.
    Silva SN; Guerreiro D; Gomes M; Azevedo AP; Bezerra De Castro G; Rueff J; Gaspar JF
    Oncol Rep; 2012 Feb; 27(2):511-6. PubMed ID: 22024983
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Single nucleotide polymorphisms in breast cancer.
    Försti A; Angelini S; Festa F; Sanyal S; Zhang Z; Grzybowska E; Pamula J; Pekala W; Zientek H; Hemminki K; Kumar R
    Oncol Rep; 2004 Apr; 11(4):917-22. PubMed ID: 15010895
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of LAPTM4B gene polymorphism with breast cancer susceptibility.
    Fan M; Liu Y; Zhou R; Zhang Q
    Cancer Epidemiol; 2012 Aug; 36(4):364-8. PubMed ID: 22270081
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An investigation of the relationship between TMPRSS6 gene expression, genetic variants and clinical findings in breast cancer.
    Mete M; Trabulus DC; Talu CK; Ozoran E; Mutlu T; Tekin B; Guven M
    Mol Biol Rep; 2020 Jun; 47(6):4225-4231. PubMed ID: 32385772
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ST14 gene variant and decreased matriptase protein expression predict poor breast cancer survival.
    Kauppinen JM; Kosma VM; Soini Y; Sironen R; Nissinen M; Nykopp TK; Kärjä V; Eskelinen M; Kataja V; Mannermaa A
    Cancer Epidemiol Biomarkers Prev; 2010 Sep; 19(9):2133-42. PubMed ID: 20716618
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic variability of TMPRSS6 and its association with iron deficiency anaemia.
    Delbini P; Vaja V; Graziadei G; Duca L; Nava I; Refaldi C; Cappellini MD
    Br J Haematol; 2010 Nov; 151(3):281–4. PubMed ID: 20738301
    [TBL] [Abstract][Full Text] [Related]  

  • 40. No association between OGG1 Ser326Cys polymorphism and breast cancer risk.
    Vogel U; Nexø BA; Olsen A; Thomsen B; Jacobsen NR; Wallin H; Overvad K; Tjønneland A
    Cancer Epidemiol Biomarkers Prev; 2003 Feb; 12(2):170-1. PubMed ID: 12582029
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.